BRONCHITIS: A COMPREHENSIVE MEDICAL GUIDE

(Note: For PDF File Swipe To The End Of Article)

1. INTRODUCTION

Bronchitis is a respiratory disorder characterized by inflammation of the bronchial tubes, which are the air passages responsible for carrying air from the trachea into the lungs. These tubes play an essential role in the respiratory system because they allow oxygen-rich air to reach the lungs and help remove carbon dioxide from the body.

When bronchitis develops, the inner lining of the bronchial tubes becomes inflamed, swollen and irritated. The affected airways may produce excessive mucus, which can partially obstruct the normal movement of air. As a result, patients commonly develop coughing, sputum production, chest discomfort, wheezing and sometimes difficulty breathing.

Bronchitis is one of the common respiratory conditions encountered in clinical practice. It can affect people of different ages, although certain individuals have a greater risk because of smoking, air pollution, occupational exposure, respiratory infections and underlying lung diseases.

The condition is broadly classified into two major types: acute bronchitis and chronic bronchitis.

Acute bronchitis usually develops following a viral respiratory infection and generally improves within a few weeks. Chronic bronchitis is a long-term inflammatory condition characterized by persistent mucus-producing cough. It is commonly associated with chronic obstructive pulmonary disease (COPD).

Understanding bronchitis is important for medical students, doctors, nurses and other healthcare professionals because its symptoms may resemble those of pneumonia, asthma, tuberculosis, influenza and other respiratory disorders.

Although most cases of acute bronchitis are self-limiting, chronic bronchitis may significantly affect lung function, physical activity and quality of life.

This comprehensive guide explains bronchitis from basic concepts to advanced clinical knowledge.

2. DEFINITION OF BRONCHITIS

Bronchitis is defined as inflammation of the bronchial mucosa, resulting in swelling of the airway lining, increased mucus production and irritation of the respiratory passages.

The bronchial tubes are normally lined with a protective mucous membrane containing epithelial cells and tiny hair-like structures called cilia.

These cilia continuously move mucus and trapped particles toward the throat, helping keep the respiratory passages clean.

During bronchitis, inflammation interferes with this protective mechanism.

The bronchial lining becomes swollen, mucus production may increase and the normal clearance of respiratory secretions becomes less effective.

This results in:

• Persistent coughing.
• Increased mucus production.
• Irritation of the respiratory passages.
• Wheezing.
• Chest discomfort.
• Difficulty breathing in some patients.

Important clinical definition:

Chronic bronchitis is classically defined as a productive cough occurring on most days for at least three months in each of two consecutive years, after excluding other possible causes of chronic cough.

This definition is important in clinical examinations and medical practice.

3. ANATOMY AND PHYSIOLOGY OF THE BRONCHIAL TREE

To understand bronchitis properly, it is important to understand the normal structure and function of the respiratory system.

The respiratory system is responsible for supplying oxygen to the body and removing carbon dioxide produced by cellular metabolism.

It consists of the upper and lower respiratory tracts.

3.1 Upper Respiratory Tract

The upper respiratory tract includes:

• Nose.
• Nasal cavity.
• Paranasal sinuses.
• Pharynx.
• Larynx.

These structures help filter, warm and humidify inhaled air before it reaches the lungs.

3.2 Lower Respiratory Tract

The lower respiratory tract includes:

• Trachea.
• Main bronchi.
• Secondary bronchi.
• Tertiary bronchi.
• Bronchioles.
• Alveoli.

The trachea divides into two main bronchi.

The right main bronchus supplies the right lung, while the left main bronchus supplies the left lung.

Each main bronchus divides repeatedly into smaller branches, eventually forming bronchioles.

The smallest respiratory passages terminate in alveolar structures, where gas exchange takes place.

3.3 Structure of the Bronchial Wall

The bronchial wall consists of several structural components.

1. Mucosal layer

The mucosal layer forms the inner lining of the bronchial tubes. It contains epithelial cells and mucus-producing structures.

2. Ciliated epithelial cells

These cells possess microscopic hair-like projections called cilia.

Their primary function is to move mucus and trapped microorganisms toward the throat.

3. Goblet cells

Goblet cells produce mucus that traps dust, bacteria, viruses and other inhaled particles.

4. Smooth muscle

Smooth muscle surrounds the bronchial passages and regulates their diameter.

Contraction of these muscles narrows the airways, while relaxation widens them.

5. Cartilage

Larger bronchi contain cartilage that helps maintain airway structure and prevents airway collapse.

3.4 Normal Function of Bronchi

Healthy bronchial tubes perform several important functions:

• Transport air toward the lungs.
• Maintain adequate airflow.
• Trap inhaled particles.
• Protect the lower respiratory tract from microorganisms.
• Remove excessive mucus through mucociliary clearance.
• Help maintain normal respiratory function.

When inflammation develops, these protective functions become impaired.

This explains why bronchitis produces coughing and excessive respiratory secretions.

4. CLASSIFICATION OF BRONCHITIS

Bronchitis is primarily classified into two major categories.

4.1 Acute Bronchitis

Acute bronchitis is a short-term inflammation of the bronchial tubes, most commonly caused by viral respiratory infections.

It often develops after a common cold, influenza or another respiratory infection.

The major clinical feature is a persistent cough, which may occur with or without sputum production.

Other symptoms include:

• Mild fever.
• Fatigue.
• Sore throat.
• Chest discomfort.
• Wheezing.
• Nasal congestion.

In most otherwise healthy individuals, acute bronchitis improves without specific antimicrobial treatment.

The cough generally resolves within approximately three weeks, although some patients experience a longer-lasting cough.

4.2 Chronic Bronchitis

Chronic bronchitis is a long-term inflammatory condition characterized by excessive mucus production and persistent productive cough.

The classical diagnostic definition requires a productive cough for at least three months in each of two consecutive years.

It is strongly associated with prolonged exposure to tobacco smoke, air pollution and occupational irritants.

Chronic bronchitis is frequently associated with COPD, although the terms are not interchangeable.

Patients may experience:

• Persistent productive cough.
• Excessive sputum.
• Breathlessness.
• Wheezing.
• Recurrent respiratory infections.
• Reduced exercise tolerance.

As the disease progresses, patients may develop significant airflow limitation and respiratory impairment.

4.3 Infectious Bronchitis

Infectious bronchitis develops when microorganisms cause inflammation of the bronchial passages.

Viruses are the most common cause of acute infectious bronchitis.

Occasionally, bacterial infections or specific respiratory pathogens may be responsible.

4.4 Irritant-Induced Bronchitis

Irritant-induced bronchial inflammation may develop after exposure to substances that damage or irritate the respiratory lining.

Examples include:

• Cigarette smoke.
• Industrial chemicals.
• Dust.
• Toxic fumes.
• Air pollution.
• Burning fuels.

Repeated exposure can produce persistent airway irritation and contribute to chronic respiratory disease.

5. EPIDEMIOLOGY

Bronchitis occurs worldwide and represents an important cause of respiratory illness.

Acute bronchitis is particularly common during periods when respiratory viruses circulate more frequently.

Chronic bronchitis is more strongly associated with prolonged environmental and occupational exposures.

5.1 Age Distribution

Acute bronchitis can occur in individuals of all age groups.

However, respiratory infections may cause more serious illness in:

• Young children.
• Older adults.
• Individuals with weakened immune systems.
• Patients with chronic respiratory diseases.

Chronic bronchitis is more commonly recognized in middle-aged and older adults because its development is frequently associated with long-term exposure to harmful inhaled substances.

5.2 Seasonal Variation

Acute bronchitis commonly occurs during colder months in many regions.

This is partly related to increased circulation of influenza viruses and other respiratory pathogens.

However, bronchitis can occur at any time of the year.

5.3 Geographic Distribution

Bronchitis occurs in developed and developing countries.

The burden of chronic respiratory disease may be greater in populations exposed to:

• Tobacco smoke.
• Household air pollution.
• Biomass fuel smoke.
• Industrial pollution.
• Occupational dust.
• Poor indoor ventilation.

In countries where wood, coal, crop residue or animal dung is used for cooking and heating, household smoke exposure may contribute significantly to chronic respiratory problems.

5.4 Sex Distribution

The distribution of bronchitis varies according to smoking patterns, occupational exposure, environmental conditions and other risk factors.

Both males and females can develop acute and chronic bronchitis.

6. CAUSES OF BRONCHITIS

The causes of bronchitis differ according to the type of disease.

Acute bronchitis is usually infectious, whereas chronic bronchitis is frequently related to prolonged exposure to respiratory irritants.

6.1 Viral Infections

Viruses are the most common cause of acute bronchitis.

Important viral causes include:

1. Influenza virus

Influenza can cause respiratory tract inflammation and may involve the bronchial passages.

Patients may experience fever, body aches, headache, fatigue and persistent cough.

2. Rhinovirus

Rhinovirus is a common cause of the common cold.

In some patients, infection may extend into the lower respiratory tract and produce bronchial irritation.

3. Respiratory syncytial virus

Respiratory syncytial virus (RSV) can cause respiratory infections, particularly in infants, young children and older adults.

4. Coronavirus

Certain coronaviruses can cause respiratory infections associated with bronchial inflammation and coughing.

5. Adenovirus

Adenovirus may cause respiratory tract infections with symptoms such as sore throat, fever and cough.

6. Parainfluenza virus

Parainfluenza viruses cause respiratory illnesses and may involve the bronchial passages.

6.2 Bacterial Infections

Bacterial causes of acute bronchitis are less common than viral causes.

Some bacterial organisms associated with bronchitis-like illness include:

• Bordetella pertussis.
• Mycoplasma pneumoniae.
• Chlamydia pneumoniae.

Bordetella pertussis causes whooping cough, which can present with prolonged severe coughing episodes.

It is important to distinguish uncomplicated acute bronchitis from pertussis and pneumonia because their management differs.

6.3 Cigarette Smoking

Cigarette smoking is one of the most important risk factors for chronic bronchitis.

Tobacco smoke contains numerous harmful chemicals that irritate and damage the respiratory epithelium.

Continuous exposure causes:

• Increased mucus production.
• Damage to ciliated epithelial cells.
• Chronic airway inflammation.
• Impaired mucus clearance.
• Structural changes in the bronchial walls.

Over time, these changes can produce persistent productive cough and airflow obstruction.

6.4 Air Pollution

Air pollution is another important contributor to respiratory inflammation.

Common pollutants include:

• Particulate matter.
• Nitrogen dioxide.
• Sulfur dioxide.
• Ozone.
• Industrial smoke.
• Vehicle exhaust.

Inhalation of these pollutants can irritate the respiratory tract and worsen existing bronchial disease.

6.5 Occupational Exposure

Certain occupations increase the risk of bronchial irritation.

Examples include:

• Mining.
• Construction.
• Agriculture.
• Textile manufacturing.
• Welding.
• Chemical manufacturing.
• Industrial cleaning.

Repeated exposure to dust, fumes and chemical vapors may contribute to chronic respiratory inflammation.

6.6 Household Air Pollution

Indoor exposure to smoke from cooking and heating fuels is an important respiratory health problem.

Poor ventilation increases the concentration of harmful airborne particles.

Long-term exposure may contribute to chronic bronchitis and COPD.

6.7 Recurrent Respiratory Infections

Repeated respiratory infections may contribute to persistent airway symptoms, particularly in individuals with pre-existing lung disease.

However, recurrent infections should prompt assessment for underlying conditions such as asthma, bronchiectasis, immune disorders or COPD.

7. RISK FACTORS

Several factors increase the likelihood of developing bronchitis.

7.1 Smoking

Smoking is a major risk factor for chronic bronchitis.

Both active smoking and exposure to secondhand smoke can damage the respiratory tract.

7.2 Older Age

Older adults may have reduced respiratory reserve and a higher likelihood of underlying cardiopulmonary disease.

This can increase the risk of complications from respiratory infections.

7.3 Weak Immune System

Individuals with weakened immune systems may be more vulnerable to respiratory infections.

Risk factors include:

• Certain immune disorders.
• Immunosuppressive medications.
• Cancer treatment.
• Advanced chronic diseases.

7.4 Occupational Dust Exposure

Long-term exposure to industrial dust and fumes can irritate bronchial tissues.

7.5 Previous Lung Disease

Patients with asthma, COPD and other chronic pulmonary conditions may experience worsening respiratory symptoms during respiratory infections.

7.6 Environmental Conditions

Living in areas with high levels of pollution and poor indoor air quality may increase respiratory risk.

7.7 Poor General Health

Malnutrition, frailty and certain chronic medical conditions may increase vulnerability to respiratory infections.

8. PATHOPHYSIOLOGY OF BRONCHITIS

Pathophysiology refers to the functional and structural changes that occur in the body during disease.

Understanding the pathophysiology of bronchitis helps explain why patients develop coughing, mucus production and breathing difficulties.

The mechanisms differ somewhat between acute and chronic bronchitis.

8.1 Initial Exposure

In acute bronchitis, a respiratory virus enters the body through inhaled respiratory particles or contaminated hands.

The microorganism reaches the respiratory tract and infects susceptible epithelial cells.

In irritant-related bronchitis, harmful particles or chemicals directly irritate the bronchial lining.

8.2 Activation of Inflammatory Response

The affected epithelial cells recognize the infection or irritant and activate the immune system.

Inflammatory mediators are released.

These include:

• Cytokines.
• Chemokines.
• Prostaglandins.
• Other inflammatory substances.

These mediators attract immune cells toward the affected bronchial tissues.

8.3 Infiltration of Inflammatory Cells

White blood cells move toward the inflamed bronchial lining.

Depending on the cause and stage of illness, these may include:

• Neutrophils.
• Macrophages.
• Lymphocytes.

Their function is to help eliminate microorganisms and remove damaged cellular material.

However, the inflammatory response also contributes to swelling and irritation.

8.4 Bronchial Mucosal Edema

Inflammation causes increased blood flow and vascular permeability.

Fluid accumulates within the bronchial tissues.

This produces mucosal edema, which narrows the airway lumen.

Narrowed airways increase resistance to airflow.

8.5 Increased Mucus Production

Goblet cells and mucus-producing glands may become more active.

Excessive mucus accumulates within the bronchial passages.

This mucus can partially obstruct airflow and stimulate cough receptors.

8.6 Impaired Mucociliary Clearance

Inflammation and irritant exposure may damage ciliated epithelial cells.

As a result, the normal movement of mucus toward the throat becomes less effective.

Secretions remain within the airways for longer periods.

This can contribute to persistent coughing and recurrent respiratory infections.

8.7 Airway Hyperresponsiveness

Inflamed bronchial passages may become unusually sensitive to environmental stimuli.

Cold air, exercise, smoke and strong odors may trigger coughing or bronchospasm.

Some patients develop temporary wheezing because of airway narrowing.

8.8 Development of Clinical Symptoms

The combined effects of inflammation, mucus accumulation and airway narrowing produce the typical symptoms of bronchitis.

These include:

• Persistent cough.
• Sputum production.
• Wheezing.
• Chest discomfort.
• Breathlessness.

8.9 Pathophysiology of Chronic Bronchitis

In chronic bronchitis, repeated exposure to tobacco smoke or other harmful substances causes persistent airway inflammation.

Several structural changes develop over time.

Goblet cell hyperplasia

The number of mucus-producing goblet cells increases.

Mucous gland enlargement

The mucus-producing glands become enlarged and more active.

Increased mucus secretion

Excess mucus accumulates in the bronchial passages.

Ciliary dysfunction

The normal clearance mechanism becomes impaired.

Airway wall thickening

Chronic inflammation produces structural changes in the bronchial walls.

Airflow limitation

Narrowed airways and mucus obstruction make it more difficult for air to move normally.

In advanced disease, chronic bronchitis may contribute to COPD, recurrent exacerbations, hypoxemia and respiratory failure.

9. CLINICAL FEATURES OF BRONCHITIS

Clinical features are the signs and symptoms observed in patients with bronchitis.

The presentation depends on the type, severity and duration of the disease.

9.1 Cough

Cough is the most characteristic symptom of bronchitis.

It develops because inflammation and mucus stimulate sensory receptors within the respiratory tract.

The cough may initially be dry.

As mucus production increases, it may become productive.

Acute bronchitis commonly produces a cough that persists for several weeks.

In chronic bronchitis, the cough may continue for months or years.

9.2 Sputum Production

Some patients produce sputum during coughing.

Sputum may be:

• Clear.
• White.
• Yellow.
• Greenish.

The color of sputum alone does not establish whether an infection is bacterial.

This is an important clinical point because colored sputum does not automatically indicate a need for antibiotics.

9.3 Wheezing

Wheezing is a high-pitched musical sound produced when air passes through narrowed respiratory passages.

It may occur because of bronchial swelling, mucus accumulation or bronchospasm.

Wheezing is more likely in patients with underlying asthma or chronic obstructive pulmonary disease.

9.4 Shortness of Breath

Some patients experience breathlessness.

This may result from airway narrowing, mucus accumulation or an associated respiratory condition.

Severe or progressive breathlessness requires urgent medical evaluation.

9.5 Chest Discomfort

Persistent coughing can strain the chest wall muscles.

Patients may complain of soreness, tightness or discomfort during coughing.

Severe chest pain should not automatically be attributed to bronchitis because cardiac and other pulmonary disorders may produce similar symptoms.

9.6 Fever

Mild fever may occur in acute infectious bronchitis.

High or persistent fever should raise suspicion for pneumonia, influenza or another significant infection.

9.7 Fatigue

Inflammation, disturbed sleep and the body's immune response may produce tiredness.

Some patients feel weak and have reduced energy for normal daily activities.

9.8 Sore Throat

A sore throat may occur when bronchitis develops as part of a broader upper respiratory infection.

9.9 Nasal Congestion

Nasal congestion and a runny nose may accompany acute bronchitis, particularly when it follows a common cold.

9.10 Headache and Body Aches

Some patients experience mild headache and generalized body aches, particularly when the underlying cause is influenza or another viral infection.

10. SIGNS OF CHRONIC BRONCHITIS

Chronic bronchitis produces persistent respiratory symptoms.

Important findings include:

• Long-standing productive cough.
• Excessive sputum production.
• Recurrent respiratory infections.
• Wheezing.
• Progressive breathlessness.
• Reduced exercise tolerance.
• Persistent fatigue.

In advanced COPD-associated disease, additional findings may include:

• Low oxygen saturation.
• Peripheral cyanosis.
• Use of accessory respiratory muscles.
• Peripheral edema in patients with associated right-sided heart failure.
• Reduced physical activity.

Not every patient develops all these features.

11. PHYSICAL EXAMINATION

Physical examination helps healthcare professionals assess the respiratory system and identify possible complications.

11.1 General Inspection

The clinician observes the patient's general appearance.

Important observations include:

• Respiratory rate.
• Breathing pattern.
• Use of accessory muscles.
• Presence of cyanosis.
• Ability to speak normally.
• Level of consciousness.
• Signs of respiratory distress.

11.2 Palpation

Palpation may help assess chest expansion and identify localized chest wall tenderness.

11.3 Percussion

Chest percussion may be normal in uncomplicated acute bronchitis.

Abnormal percussion findings may suggest another condition, such as pneumonia, pleural effusion or hyperinflation associated with COPD.

11.4 Auscultation

Auscultation is performed using a stethoscope.

Possible findings include:

Rhonchi: Low-pitched sounds associated with secretions in larger airways.

Wheezing: Musical sounds caused by narrowed airways.

Crackles: May suggest associated pneumonia or another pulmonary process.

Breath sounds may be normal in uncomplicated acute bronchitis.

Clinical findings must always be interpreted together with the patient's history and overall condition.

12. DIAGNOSIS OF BRONCHITIS

The diagnosis of acute bronchitis is generally clinical.

This means that healthcare professionals primarily use the patient's history, symptoms and physical examination.

Investigations are performed when necessary to exclude other respiratory conditions or assess chronic disease.

12.1 Medical History

A detailed medical history is important.

The healthcare professional asks about:

• Duration of cough.
• Presence of sputum.
• Fever.
• Breathlessness.
• Wheezing.
• Chest pain.
• Smoking history.
• Occupational exposure.
• Previous respiratory infections.
• Existing lung diseases.
• Medication history.

The duration of symptoms is particularly important for distinguishing acute from chronic bronchitis.

12.2 Physical Examination

The clinician evaluates respiratory rate, oxygenation, chest movement and breath sounds.

Abnormal vital signs or focal chest findings may suggest pneumonia.

12.3 Chest X-Ray

A chest X-ray is not routinely required in otherwise healthy patients with uncomplicated acute bronchitis.

It may be indicated when pneumonia or another pulmonary condition is suspected.

Possible reasons include:

• Significant breathlessness.
• Persistent high fever.
• Low oxygen saturation.
• Abnormal vital signs.
• Focal lung findings.
• Clinical deterioration.

Chest radiography may help identify pulmonary infiltrates, consolidation, masses or other abnormalities.

However, a normal chest X-ray does not independently establish the diagnosis of bronchitis.

12.4 Complete Blood Count

A complete blood count (CBC) may be requested in selected patients.

It provides information about:

• Hemoglobin.
• White blood cell count.
• Platelet count.
• Differential leukocyte count.

An increased white blood cell count may occur with infection or inflammation.

However, CBC findings alone cannot reliably distinguish viral from bacterial bronchitis.

12.5 Sputum Examination

Sputum testing is not routinely necessary in uncomplicated acute bronchitis.

It may be considered in selected patients with chronic lung disease, severe infection, unusual clinical features or suspected resistant organisms.

12.6 Pulse Oximetry

Pulse oximetry measures peripheral oxygen saturation.

It is useful in patients with breathlessness, suspected hypoxemia or significant underlying respiratory disease.

12.7 Spirometry

Spirometry is an important investigation when chronic airflow obstruction is suspected.

It measures the amount and speed of air a person can exhale.

It is particularly useful for evaluating COPD and distinguishing persistent airflow obstruction from other causes of respiratory symptoms.

A post-bronchodilator FEV1/FVC ratio below 0.70 supports the diagnosis of COPD in the appropriate clinical context.

Spirometry is not usually necessary for uncomplicated acute bronchitis.

12.8 Other Investigations

Depending on the clinical presentation, healthcare professionals may request:

• Viral testing.
• Influenza testing.
• COVID-19 testing.
• Pertussis testing.
• Arterial blood gas analysis.
• Electrocardiography.
• Additional pulmonary investigations.

The choice of investigation depends on the suspected diagnosis and the patient's clinical condition.

13. DIFFERENTIAL DIAGNOSIS

Several respiratory and cardiovascular conditions can resemble bronchitis.

Correct diagnosis is important because the treatment of these disorders may differ significantly.

13.1 Pneumonia

Pneumonia is an infection involving the lung parenchyma, particularly the alveoli.

Symptoms include:

• Cough.
• Fever.
• Breathlessness.
• Chest pain.
• Fatigue.
• Sometimes sputum production.

Unlike uncomplicated acute bronchitis, pneumonia may produce infiltrates or consolidation on chest imaging.

13.2 Asthma

Asthma is a chronic inflammatory airway disorder characterized by variable respiratory symptoms and variable expiratory airflow limitation.

Common symptoms include:

• Wheezing.
• Coughing.
• Chest tightness.
• Breathlessness.

Symptoms may worsen at night, during exercise or after exposure to allergens.

Spirometry and clinical assessment help establish the diagnosis.

13.3 Chronic Obstructive Pulmonary Disease

COPD is a chronic respiratory condition characterized by persistent respiratory symptoms and airflow obstruction.

It commonly includes emphysema and chronic bronchitis-related airway disease.

Patients may experience persistent cough, sputum production and progressive breathlessness.

13.4 Tuberculosis

Pulmonary tuberculosis is an infectious disease caused by Mycobacterium tuberculosis.

Important clinical features include:

• Persistent cough.
• Fever.
• Night sweats.
• Weight loss.
• Fatigue.
• Sometimes blood in sputum.

In regions where tuberculosis is common, prolonged cough should prompt appropriate evaluation.

13.5 Influenza

Influenza is an acute viral respiratory infection.

It commonly produces fever, headache, muscle pain, fatigue and cough.

Influenza may also involve the lower respiratory tract and cause bronchitis or pneumonia.

13.6 Pertussis

Pertussis is a contagious respiratory infection caused by Bordetella pertussis.

It may cause severe coughing episodes, sometimes followed by a characteristic inspiratory whoop or vomiting.

Prolonged coughing should raise suspicion in appropriate clinical circumstances.

13.7 Heart Failure

Heart failure may produce cough and breathlessness because of pulmonary congestion.

Other features may include:

• Orthopnea.
• Paroxysmal nocturnal dyspnea.
• Leg swelling.
• Reduced exercise tolerance.

Cardiac evaluation may be necessary when these symptoms are present.

14. MANAGEMENT OF ACUTE BRONCHITIS

The management of acute bronchitis primarily focuses on relieving symptoms, maintaining hydration and monitoring for complications.

Most uncomplicated cases resolve without antibiotics.

14.1 General Supportive Care

Supportive care is the mainstay of treatment.

Important measures include:

Adequate rest

Patients should get sufficient rest during the acute illness.

Rest helps reduce physical exhaustion and supports recovery.

Adequate fluid intake

Drinking sufficient fluids helps prevent dehydration.

Warm fluids may provide temporary relief from throat irritation.

Avoidance of smoke

Patients should avoid cigarette smoke, secondhand smoke and other respiratory irritants.

Humidified air

A clean humidifier may help some patients feel more comfortable in dry environments.

Humidifiers must be cleaned properly to prevent microbial contamination.

14.2 Antipyretics and Analgesics

Patients with fever, headache or body aches may benefit from appropriate fever-relieving or pain-relieving medications.

Examples include:

• Paracetamol.
• Ibuprofen.

Medication selection should consider age, pregnancy, kidney disease, liver disease, gastrointestinal disorders and other contraindications.

14.3 Cough Management

Cough is an important protective reflex that helps clear respiratory secretions.

Not every cough needs to be suppressed.

Selected patients may benefit from symptom-relieving treatments after assessment by a healthcare professional.

Honey may soothe coughing in individuals older than one year.

Honey must never be given to infants younger than one year because of the risk of infant botulism.

14.4 Bronchodilators

Bronchodilators relax airway smooth muscle and improve airflow.

Examples include:

• Salbutamol.
• Other inhaled beta-2 agonists.

They are not routinely recommended for every patient with acute bronchitis.

They may be considered when clinically significant wheezing or bronchospasm is present.

14.5 Antibiotics

Antibiotics are generally not recommended for uncomplicated acute bronchitis because most cases are caused by viruses.

Antibiotics act against susceptible bacteria, not viruses.

Unnecessary antibiotic use may cause:

• Allergic reactions.
• Diarrhea.
• Nausea.
• Other adverse effects.
• Antibiotic resistance.
• Clostridioides difficile infection.

Antibiotics may be appropriate when a separate bacterial infection, such as pertussis or bacterial pneumonia, is diagnosed or strongly suspected.

The decision must be made by a qualified healthcare professional.

14.6 Antiviral Medication

Antiviral medications may be appropriate when a specific viral infection, such as influenza, is identified or strongly suspected and the patient meets treatment criteria.

They are not routinely prescribed for ordinary uncomplicated viral bronchitis.

15. MANAGEMENT OF CHRONIC BRONCHITIS

Chronic bronchitis requires a different approach from uncomplicated acute bronchitis.

The main goals are to:

• Reduce respiratory symptoms.
• Improve airflow.
• Prevent exacerbations.
• Improve exercise tolerance.
• Reduce exposure to harmful substances.
• Preserve quality of life.
• Identify and treat associated COPD.

15.1 Smoking Cessation

Stopping smoking is one of the most important interventions.

Continued smoking causes ongoing airway irritation and contributes to progressive lung damage.

Smoking cessation may involve:

• Behavioral counseling.
• Nicotine replacement therapy.
• Prescription smoking-cessation medications when appropriate.
• Support groups.
• Regular follow-up.

Healthcare professionals should encourage every patient who smokes to consider a structured cessation program.

15.2 Bronchodilator Therapy

In patients with COPD-associated chronic bronchitis, inhaled bronchodilators are important treatment options.

These medications relax airway smooth muscle and improve airflow.

Major categories include:

Short-acting beta-2 agonists

Examples include salbutamol.

They provide relatively rapid relief of bronchospasm.

Long-acting beta-2 agonists

These medications provide prolonged bronchodilation.

Short-acting muscarinic antagonists

These medications block muscarinic receptors and reduce cholinergic bronchoconstriction.

Long-acting muscarinic antagonists

These provide sustained bronchodilation and are commonly used in COPD management.

The choice of inhaler depends on symptoms, exacerbation history, lung function and individual patient characteristics.

15.3 Inhaled Corticosteroids

Inhaled corticosteroids reduce airway inflammation.

They may be appropriate for selected patients with COPD, particularly those with certain exacerbation patterns or coexisting asthma.

They are not routinely indicated for every patient with chronic bronchitis.

Potential adverse effects include:

• Oral candidiasis.
• Hoarseness.
• Increased risk of pneumonia in certain COPD populations.

Patients should be taught to rinse their mouth after using an inhaled corticosteroid.

15.4 Combination Inhalers

Some patients require combination inhalers containing two or more respiratory medications.

Examples include:

• LABA plus LAMA.
• LABA plus inhaled corticosteroid.
• Triple therapy containing LABA, LAMA and inhaled corticosteroid.

Treatment should be individualized according to current COPD guidelines.

15.5 Mucolytic Therapy

Mucolytic medications help reduce the viscosity of respiratory secretions.

Selected patients with chronic bronchitis may benefit from these medications.

Their usefulness depends on the underlying disease, symptom burden and treatment guidelines.

15.6 Pulmonary Rehabilitation

Pulmonary rehabilitation is an important component of chronic respiratory disease management.

It combines:

• Supervised exercise training.
• Breathing exercises.
• Patient education.
• Nutritional advice.
• Psychological support.
• Self-management strategies.

It can improve exercise capacity, reduce breathlessness and improve quality of life.

15.7 Oxygen Therapy

Long-term oxygen therapy may be prescribed to selected patients with chronic severe resting hypoxemia.

Oxygen should not be prescribed automatically to every patient with bronchitis or COPD.

The need for oxygen must be assessed using appropriate clinical and oxygenation measurements.

15.8 Vaccination

Vaccination helps reduce the risk of certain respiratory infections.

Depending on age, health status and local recommendations, vaccines may include:

• Influenza vaccine.
• Pneumococcal vaccine.
• COVID-19 vaccine.
• Pertussis-containing vaccines.
• RSV vaccines for eligible populations.

16. MANAGEMENT OF ACUTE EXACERBATION OF CHRONIC BRONCHITIS

An acute exacerbation refers to a worsening of respiratory symptoms beyond the patient's usual day-to-day variation.

It may involve:

• Increased breathlessness.
• Increased cough.
• Increased sputum production.
• Changes in sputum characteristics.
• Increased wheezing.

Respiratory infections and environmental pollutants are common triggers.

16.1 Initial Assessment

The healthcare team assesses:

• Respiratory rate.
• Heart rate.
• Blood pressure.
• Temperature.
• Oxygen saturation.
• Level of consciousness.
• Work of breathing.
• Severity of breathlessness.

16.2 Bronchodilator Treatment

Short-acting bronchodilators may be used to improve airflow during an exacerbation.

The route and method of administration depend on the patient's condition.

16.3 Corticosteroids

Systemic corticosteroids may be prescribed for selected COPD exacerbations to reduce airway inflammation and improve recovery.

Their use should follow clinical guidelines and consider contraindications.

16.4 Antibiotics

Antibiotics may be appropriate in selected COPD exacerbations when bacterial infection is suspected according to clinical findings and guideline criteria.

They are not necessary for every exacerbation.

16.5 Oxygen Therapy

Oxygen is administered when indicated by oxygenation measurements.

In patients at risk of hypercapnic respiratory failure, oxygen must be carefully controlled according to clinical guidance.

16.6 Ventilatory Support

Some patients develop acute respiratory failure.

Non-invasive ventilation may be required in selected patients with acute hypercapnic respiratory failure.

More severe cases may require intensive care and invasive mechanical ventilation.

17. NURSING MANAGEMENT OF BRONCHITIS

Nursing care plays an essential role in the assessment, treatment, monitoring and rehabilitation of patients with bronchitis.

Nurses help improve respiratory comfort, identify deterioration and educate patients about disease prevention.

17.1 Nursing Assessment

The nurse should collect a detailed history and assess the patient's current respiratory condition.

Important assessment points include:

• Nature and duration of cough.
• Amount and color of sputum.
• Presence of fever.
• Degree of breathlessness.
• Presence of chest discomfort.
• Smoking history.
• Occupational exposure.
• Previous respiratory diseases.
• Medication history.
• Nutritional status.

17.2 Monitor Vital Signs

Regular monitoring helps identify deterioration.

The nurse should assess:

• Temperature.
• Pulse rate.
• Respiratory rate.
• Blood pressure.
• Oxygen saturation.

Abnormal findings should be reported promptly.

17.3 Assess Respiratory Status

Observe the patient's breathing pattern.

Look for:

• Increased respiratory effort.
• Nasal flaring.
• Use of accessory muscles.
• Cyanosis.
• Difficulty speaking.
• Altered mental status.

These findings may indicate respiratory compromise.

17.4 Maintain Airway Clearance

Encourage appropriate coughing techniques and mobilization of secretions.

Patients should be encouraged to drink adequate fluids when not medically restricted.

Positioning may also help improve respiratory comfort.

17.5 Positioning

A semi-Fowler's or Fowler's position may help patients who experience breathlessness.

Elevating the head of the bed can improve comfort and facilitate breathing.

17.6 Administer Prescribed Medications

The nurse should administer medications according to the prescribed treatment plan.

These may include:

• Bronchodilators.
• Antipyretics.
• Selected corticosteroids.
• Prescribed antibiotics when indicated.
• Oxygen therapy.

The nurse should monitor therapeutic responses and adverse effects.

17.7 Oxygen Monitoring

If oxygen is prescribed, the nurse should monitor oxygen saturation and assess the patient's respiratory condition.

Oxygen flow and target saturation should follow the clinical prescription.

17.8 Encourage Adequate Nutrition

Patients with chronic respiratory disease may experience fatigue during eating.

The nurse can encourage small, frequent meals when appropriate.

Adequate nutrition supports general health and recovery.

17.9 Promote Rest

Persistent coughing can interfere with sleep.

The nurse should help patients maintain a comfortable environment and balance activity with adequate rest.

17.10 Infection Prevention

Important measures include:

• Hand hygiene.
• Respiratory hygiene.
• Proper disposal of tissues.
• Appropriate use of personal protective equipment.
• Cleaning frequently touched surfaces.
• Avoiding unnecessary exposure to infected individuals.

17.11 Patient Education

Patients should understand:

• The importance of smoking cessation.
• The need to avoid respiratory irritants.
• Correct inhaler technique.
• The importance of vaccination.
• Warning signs of respiratory deterioration.
• The importance of follow-up appointments.

18. NURSING DIAGNOSES

Depending on the patient's clinical condition, appropriate nursing diagnoses may include:

1. Ineffective Airway Clearance

Related to excessive mucus production and airway inflammation.

Possible evidence includes productive cough, abnormal breath sounds and difficulty clearing secretions.

2. Ineffective Breathing Pattern

Related to airway narrowing and respiratory discomfort.

Possible evidence includes abnormal respiratory rate and increased work of breathing.

3. Impaired Gas Exchange

This diagnosis may apply when significant pulmonary impairment produces inadequate oxygenation or carbon dioxide removal.

4. Activity Intolerance

Related to fatigue, breathlessness and reduced exercise capacity.

5. Disturbed Sleep Pattern

Related to persistent nighttime coughing and respiratory discomfort.

6. Deficient Knowledge

Related to insufficient understanding of the disease, medication use and preventive measures.

7. Risk for Infection

This may be relevant in patients with impaired respiratory defenses or underlying chronic disease.

19. COMPLICATIONS OF BRONCHITIS

Most cases of uncomplicated acute bronchitis resolve without serious complications.

However, complications may develop in vulnerable patients or individuals with chronic respiratory disease.

19.1 Pneumonia

Pneumonia is an important condition that may coexist with or develop following a respiratory infection.

It involves infection and inflammation of the lung tissue.

Symptoms may include high fever, breathlessness, chest pain and worsening cough.

19.2 Chronic Cough

Some patients continue coughing after the initial respiratory infection has resolved.

This may be due to persistent airway irritation or temporary airway hyperresponsiveness.

A prolonged cough should be evaluated to exclude other conditions.

19.3 Recurrent Respiratory Infections

Patients with chronic airway disease may experience repeated respiratory infections.

Impaired mucus clearance can contribute to this problem.

19.4 COPD

Chronic bronchitis is an important clinical phenotype associated with COPD.

Long-term exposure to harmful substances may lead to persistent airflow obstruction.

19.5 Respiratory Failure

Severe chronic respiratory disease or an acute exacerbation may cause respiratory failure.

Respiratory failure occurs when the lungs cannot maintain adequate oxygenation or appropriate carbon dioxide removal.

19.6 Pulmonary Hypertension

Advanced chronic lung disease may cause prolonged low oxygen levels and changes in the pulmonary circulation.

This can contribute to pulmonary hypertension.

19.7 Cor Pulmonale

Cor pulmonale refers to structural or functional changes in the right side of the heart resulting from pulmonary hypertension associated with lung disease.

It may develop in advanced chronic respiratory disorders.

19.8 Reduced Quality of Life

Persistent coughing, breathlessness and fatigue may interfere with:

• Sleep.
• Physical activity.
• Employment.
• Social activities.
• Daily living.

Psychological effects may include anxiety and depression.

20. DIFFERENCE BETWEEN ACUTE AND CHRONIC BRONCHITIS

Understanding the differences between acute and chronic bronchitis is essential for clinical practice.

Acute bronchitis

• Usually short-term.
• Commonly caused by viruses.
• Often follows a respiratory infection.
• Main symptom is persistent cough.
• Usually improves within a few weeks.
• Antibiotics are generally unnecessary.
• Usually resolves without permanent airflow obstruction.

Chronic bronchitis

• Long-term condition.
• Commonly associated with smoking and harmful inhaled exposures.
• Characterized by persistent productive cough.
• Classical definition requires symptoms for three months in two consecutive years.
• May be associated with COPD.
• Requires long-term management.
• Can significantly impair respiratory function.

21. BRONCHITIS IN CHILDREN

Bronchitis can occur in children, particularly during periods of increased viral respiratory infections.

Acute bronchitis is often associated with common respiratory viruses.

21.1 Clinical Features

Children may develop:

• Cough.
• Runny nose.
• Fever.
• Sore throat.
• Reduced appetite.
• Fatigue.
• Wheezing.
• Irritability.

Young children may have difficulty explaining their symptoms.

Parents and healthcare professionals should observe changes in feeding, activity and breathing.

21.2 Diagnosis

Diagnosis is generally based on clinical assessment.

The clinician evaluates:

• Age.
• Duration of cough.
• Respiratory rate.
• Fever.
• Feeding.
• Hydration.
• Oxygen saturation when indicated.
• Signs of respiratory distress.

Other conditions, such as bronchiolitis, pneumonia, asthma and pertussis, may need to be considered.

21.3 Treatment

Management generally involves supportive care.

Important measures include:

• Adequate fluids.
• Rest.
• Appropriate fever management.
• Nasal saline when needed.
• Monitoring of breathing.
• Medical assessment when symptoms worsen.

Over-the-counter cough and cold medicines should not be routinely given to young children without appropriate professional advice.

Antibiotics are not routinely indicated for uncomplicated viral bronchitis.

21.4 Warning Signs in Children

Seek urgent medical attention if a child develops:

• Rapid or difficult breathing.
• Chest retractions.
• Blue or grey lips.
• Severe lethargy.
• Inability to drink or feed.
• Signs of dehydration.
• Unusual drowsiness.

A fever in an infant younger than three months requires prompt medical assessment.

22. BRONCHITIS IN OLDER ADULTS

Older adults may experience more serious consequences from respiratory infections because of reduced physiological reserve and the presence of chronic medical conditions.

They may also have underlying COPD, heart disease, diabetes or kidney disease.

Important concerns include:

• Increased risk of pneumonia.
• Dehydration.
• Reduced mobility.
• Worsening of existing respiratory disease.
• Hypoxemia.
• Delayed recovery.

Early assessment is important when symptoms worsen or breathing becomes difficult.

23. BRONCHITIS AND SMOKING

Smoking is a major preventable cause of chronic respiratory disease.

Tobacco smoke contains harmful substances that damage the respiratory epithelium.

Continuous exposure can produce chronic inflammation and structural changes.

23.1 Effects of Smoking on Bronchi

Smoking can cause:

• Increased mucus secretion.
• Ciliary dysfunction.
• Persistent airway irritation.
• Chronic inflammation.
• Reduced mucociliary clearance.
• Increased susceptibility to respiratory infections.

23.2 Passive Smoking

Secondhand smoke also contains harmful substances.

People who do not smoke may still experience respiratory irritation when exposed to tobacco smoke.

Children are particularly vulnerable to the harmful effects of secondhand smoke.

23.3 Benefits of Smoking Cessation

Stopping smoking can:

• Reduce further exposure to airway irritants.
• Improve respiratory health.
• Reduce coughing over time.
• Slow the progression of smoking-related lung damage.
• Reduce the risk of several smoking-related diseases.

Smoking cessation remains beneficial even in patients with established chronic bronchitis or COPD.

24. BRONCHITIS AND AIR POLLUTION

Air pollution is an important environmental risk factor for respiratory disease.

People living in heavily polluted areas may be exposed to harmful gases and particulate matter.

24.1 Sources of Air Pollution

Common sources include:

• Vehicle emissions.
• Industrial factories.
• Burning waste.
• Construction dust.
• Household cooking smoke.
• Coal and biomass fuels.
• Tobacco smoke.

24.2 Effects on Respiratory Health

Air pollution may cause:

• Airway irritation.
• Increased coughing.
• Respiratory inflammation.
• Exacerbation of asthma.
• Worsening of COPD.
• Increased susceptibility to respiratory symptoms.

24.3 Preventive Measures

People can reduce exposure by:

• Avoiding heavily polluted environments when possible.
• Improving indoor ventilation.
• Avoiding indoor smoking.
• Using cleaner cooking fuels.
• Following local air-quality information.
• Using suitable respiratory protection in occupational settings.

25. PREVENTION OF BRONCHITIS

Preventive measures are important for reducing respiratory infections and long-term airway damage.

25.1 Avoid Smoking

Avoiding tobacco smoke is one of the most effective ways to protect the respiratory system.

People who smoke should be encouraged to stop.

25.2 Hand Hygiene

Regular handwashing reduces the spread of respiratory microorganisms.

Hands should be washed with soap and water, particularly after coughing, sneezing or contact with respiratory secretions.

25.3 Respiratory Hygiene

People should cover their mouth and nose when coughing or sneezing.

Used tissues should be disposed of properly.

25.4 Vaccination

Recommended vaccines help reduce the risk of selected respiratory infections.

These may include influenza, COVID-19 and pneumococcal vaccines, depending on age and individual medical risk.

25.5 Avoid Air Pollution

Reduce exposure to dust, smoke and chemical fumes whenever possible.

25.6 Occupational Protection

Workers exposed to harmful substances should follow workplace safety recommendations.

Appropriate ventilation and respiratory protective equipment may be necessary.

25.7 Healthy Lifestyle

A healthy lifestyle supports general immune and respiratory health.

Important measures include:

• Balanced nutrition.
• Regular physical activity.
• Adequate sleep.
• Appropriate hydration.
• Management of chronic medical conditions.

26. PROGNOSIS

The prognosis of bronchitis depends on its type, underlying cause and the patient's general health.

26.1 Prognosis of Acute Bronchitis

The prognosis is generally excellent in otherwise healthy individuals.

Most patients recover without permanent respiratory damage.

The cough may continue for several weeks even after other symptoms improve.

26.2 Prognosis of Chronic Bronchitis

The prognosis varies according to the severity of airway disease, smoking history, lung function and associated conditions.

Chronic bronchitis may remain relatively stable in some individuals, while others develop progressive airflow limitation and COPD.

Early recognition, smoking cessation and appropriate long-term management can improve outcomes.

27. WHEN TO SEEK MEDICAL ATTENTION

Although bronchitis is commonly a mild illness, certain symptoms require medical evaluation.

Medical assessment is particularly important when a patient develops:

• Cough lasting more than three weeks.
• Blood in sputum.
• Persistent or high fever.
• Shortness of breath.
• Chest pain.
• Recurrent episodes of bronchitis.
• Worsening symptoms.
• Significant weakness.
• Poor oral intake or dehydration.

Emergency medical attention is required when a patient experiences:

• Severe difficulty breathing.
• Blue or grey lips or skin.
• Confusion or reduced consciousness.
• Inability to speak because of breathlessness.
• Severe respiratory distress.

These symptoms may indicate a serious respiratory or cardiovascular condition.

28. IMPORTANT LABORATORY AND CLINICAL TERMS

Medical students should understand several terms commonly used when studying bronchitis.

Bronchial inflammation: Inflammation involving the lining of the bronchial tubes.

Mucus: A protective secretion produced by mucous glands and goblet cells.

Sputum: Respiratory secretions expelled through coughing.

Mucociliary clearance: The process through which cilia move mucus and trapped particles out of the respiratory passages.

Bronchospasm: Contraction of bronchial smooth muscle, resulting in airway narrowing.

Wheezing: A musical respiratory sound caused by airflow through narrowed airways.

Dyspnea: The subjective sensation of difficulty breathing.

Cyanosis: Bluish discoloration associated with increased deoxygenated hemoglobin or abnormal hemoglobin pigments.

Hypoxemia: Abnormally low oxygen concentration in arterial blood.

Hypercapnia: Increased carbon dioxide concentration in arterial blood.

Spirometry: A pulmonary function test used to measure airflow and lung volumes that can be assessed through breathing maneuvers.

FEV1: Forced expiratory volume in one second.

FVC: Forced vital capacity.

COPD: Chronic obstructive pulmonary disease.

Exacerbation: An acute worsening of symptoms beyond the patient's usual condition.

29. IMPORTANT MEDICATION CLASSES USED IN BRONCHITIS-RELATED CONDITIONS

Different medications may be used depending on whether the patient has acute bronchitis, chronic bronchitis or associated COPD.

29.1 Bronchodilators

These medications relax bronchial smooth muscle.

Examples include:

• Salbutamol.
• Formoterol.
• Salmeterol.
• Ipratropium.
• Tiotropium.

29.2 Corticosteroids

Corticosteroids reduce inflammation in selected respiratory conditions.

Examples include:

• Budesonide.
• Beclometasone.
• Prednisolone.

They are not routinely necessary for uncomplicated acute bronchitis.

29.3 Mucolytics

Mucolytics help reduce the thickness of respiratory secretions.

Examples include:

• Acetylcysteine.
• Carbocisteine.

Their use depends on the underlying respiratory condition and clinical recommendations.

29.4 Antipyretics

These medications help relieve fever and associated discomfort.

Examples include:

• Paracetamol.
• Ibuprofen.

29.5 Antibiotics

Antibiotics are used only when a suitable bacterial indication exists.

Examples of antibiotics that may be used for particular bacterial respiratory infections include:

• Amoxicillin.
• Doxycycline.
• Azithromycin.

The appropriate drug depends on the diagnosis, patient characteristics, allergies, local resistance patterns and clinical guidelines.

Antibiotics should never be self-prescribed for ordinary acute bronchitis.

30. PATIENT EDUCATION

Patient education is an essential component of bronchitis management.

Healthcare professionals should explain the nature of the condition and the expected recovery period.

Important educational points include:

1. Understand the disease

Patients should know that acute bronchitis is commonly caused by viruses and usually improves with time.

2. Avoid smoking

Smoking can worsen airway inflammation and increase the risk of chronic respiratory disease.

3. Maintain hydration

Adequate fluid intake helps prevent dehydration.

4. Follow medication instructions

Patients should use prescribed medications correctly and avoid unnecessary antibiotics.

5. Practice infection prevention

Handwashing and respiratory hygiene reduce the spread of respiratory infections.

6. Attend follow-up appointments

Patients with persistent symptoms or chronic respiratory disease may require regular medical review.

7. Recognize danger signs

Patients should seek medical help when they develop significant breathlessness, blood in sputum, persistent fever or worsening symptoms.